1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
CIS PROLINE - PRO 75 MODEL 1
CIS PROLINE - PRO 75 MODEL 2
CIS PROLINE - PRO 75 MODEL 3
CIS PROLINE - PRO 75 MODEL 4
CIS PROLINE - PRO 75 MODEL 5
CIS PROLINE - PRO 75 MODEL 6
CIS PROLINE - PRO 75 MODEL 7
CIS PROLINE - PRO 75 MODEL 8
CIS PROLINE - PRO 75 MODEL 9
CIS PROLINE - PRO 75 MODEL 10
CIS PROLINE - PRO 75 MODEL 11
CIS PROLINE - PRO 75 MODEL 12
CIS PROLINE - PRO 75 MODEL 13
CIS PROLINE - PRO 75 MODEL 14
CIS PROLINE - PRO 75 MODEL 15
CIS PROLINE - PRO 75 MODEL 16
CIS PROLINE - PRO 75 MODEL 17
CIS PROLINE - PRO 75 MODEL 18
CIS PROLINE - PRO 75 MODEL 19
CIS PROLINE - PRO 75 MODEL 20
CIS PROLINE - PRO 75 MODEL 21
CIS PROLINE - PRO 75 MODEL 22
CIS PROLINE - PRO 75 MODEL 23
CIS PROLINE - PRO 75 MODEL 24
CIS PROLINE - PRO 75 MODEL 25
CIS PROLINE - PRO 75 MODEL 26
CIS PROLINE - PRO 75 MODEL 27
CIS PROLINE - PRO 75 MODEL 28
CIS PROLINE - PRO 75 MODEL 29
CIS PROLINE - PRO 75 MODEL 30
CIS PROLINE - PRO 75 MODEL 31
CIS PROLINE - PRO 75 MODEL 32
CIS PROLINE - PRO 75 MODEL 33
CIS PROLINE - PRO 75 MODEL 34
CIS PROLINE - PRO 75 MODEL 35
CIS PROLINE - PRO 75 MODEL 36
CIS PROLINE - PRO 75 MODEL 37
CIS PROLINE - PRO 75 MODEL 38
CIS PROLINE - PRO 75 MODEL 39
CIS PROLINE - PRO 75 MODEL 40
Clore, G.M.
Qin, J.
Gronenborn, A.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
2
503
522
10.1016/S0969-2126(00)00051-4
7922028
The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin.
1994
10.2210/pdb1tru/pdb
pdb_00001tru
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11624.190
THIOREDOXIN
1
man
polymer
18.015
water
7
nat
water
no
no
MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDAQDVASEAEVKATPTFQFF
KKGQKVGEFSGANKEKLEATINELV
MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDAQDVASEAEVKATPTFQFF
KKGQKVGEFSGANKEKLEATINELV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1994-09-30
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1994-05-10
REL
HOH
water
40
THE 3D STRUCTURE OF OXIDIZED HUMAN THIOREDOXIN IN SOLUTION
BY NMR IS BASED ON 3018 EXPERIMENTAL RESTRAINTS COMPRISING:
2649 STRUCTURE USEFUL INTERPROTON DISTANCE RESTRAINTS; 34
RESTRAINTS FOR 17 H-BONDS INVOLVING 7 TIGHTLY BOUND WATER
MOLECULES; 42 RESTRAINTS FOR 21 BACKBONE HYDROGEN BONDS
INVOLVING SLOWLY EXCHANGING AMIDE PROTONS; 278 TORSION
ANGLE RESTRAINTS (104 PHI, 76 PSI, 78 CHI1 AND 20 CHI2);
AND 91 HN-HALPHA THREE-BOND COUPLING CONSTANTS. A
COMPLETE LIST OF EXPERIMENTAL RESTRAINTS AND 1H, 13C AND
15N ASSIGNMENTS HAVE BEEN DEPOSITED WITH THE PROTEIN DATA
BANK.
THE STRUCTURES ARE CALCULATED USING THE HYBRID METRIC
MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING
METHOD DESCRIBED BY: NILGES, M., CLORE, G.M. &
GRONENBORN, A.M. (1988) FEBS LETT 229, 317 - 324. ALL
STRUCTURAL STATISTICS ARE GIVEN IN THE REFERENCE.
THE RESTRAINED MINIMIZED AVERAGE STRUCTURE (SA)R IS
PRESENTED IN PROTEIN DATA BANK ENTRY 1TRS. THIS IS
OBTAINED BY FIRST AVERAGING THE COORDINATES OF THE
INDIVIDUAL 40 DYNAMICAL SIMULATED ANNEALING SA STRUCTURES
BEST FITTED TO RESIDUES 1 - 105, AND SUBJECTING THE
RESULTING COORDINATES TO RESTRAINED MINIMIZATION.
COLUMNS 61 - 65 OF THE COORDINATE RECORDS (THE B VALUE
FIELD IN X-RAY STRUCTURES) IN THE MINIMIZED STRUCTURE
(ENTRY 1TRS) GIVE THE AVERAGE RMS DIFFERENCE BETWEEN THE
INDIVIDUAL SA STRUCTURES AND THE MEAN STRUCTURE. THE
NUMBERS IN THIS FIELD OF THE INDIVIDUAL STRUCTURES (ENTRY
1TRU) HAVE NO MEANING.
HOH
201
2
HOH
HOH
201
A
HOH
202
2
HOH
HOH
202
A
HOH
203
2
HOH
HOH
203
A
HOH
204
2
HOH
HOH
204
A
HOH
205
2
HOH
HOH
205
A
HOH
206
2
HOH
HOH
206
A
HOH
207
2
HOH
HOH
207
A
MET
1
n
1
MET
1
A
VAL
2
n
2
VAL
2
A
LYS
3
n
3
LYS
3
A
GLN
4
n
4
GLN
4
A
ILE
5
n
5
ILE
5
A
GLU
6
n
6
GLU
6
A
SER
7
n
7
SER
7
A
LYS
8
n
8
LYS
8
A
THR
9
n
9
THR
9
A
ALA
10
n
10
ALA
10
A
PHE
11
n
11
PHE
11
A
GLN
12
n
12
GLN
12
A
GLU
13
n
13
GLU
13
A
ALA
14
n
14
ALA
14
A
LEU
15
n
15
LEU
15
A
ASP
16
n
16
ASP
16
A
ALA
17
n
17
ALA
17
A
ALA
18
n
18
ALA
18
A
GLY
19
n
19
GLY
19
A
ASP
20
n
20
ASP
20
A
LYS
21
n
21
LYS
21
A
LEU
22
n
22
LEU
22
A
VAL
23
n
23
VAL
23
A
VAL
24
n
24
VAL
24
A
VAL
25
n
25
VAL
25
A
ASP
26
n
26
ASP
26
A
PHE
27
n
27
PHE
27
A
SER
28
n
28
SER
28
A
ALA
29
n
29
ALA
29
A
THR
30
n
30
THR
30
A
TRP
31
n
31
TRP
31
A
CYS
32
n
32
CYS
32
A
GLY
33
n
33
GLY
33
A
PRO
34
n
34
PRO
34
A
CYS
35
n
35
CYS
35
A
LYS
36
n
36
LYS
36
A
MET
37
n
37
MET
37
A
ILE
38
n
38
ILE
38
A
LYS
39
n
39
LYS
39
A
PRO
40
n
40
PRO
40
A
PHE
41
n
41
PHE
41
A
PHE
42
n
42
PHE
42
A
HIS
43
n
43
HIS
43
A
SER
44
n
44
SER
44
A
LEU
45
n
45
LEU
45
A
SER
46
n
46
SER
46
A
GLU
47
n
47
GLU
47
A
LYS
48
n
48
LYS
48
A
TYR
49
n
49
TYR
49
A
SER
50
n
50
SER
50
A
ASN
51
n
51
ASN
51
A
VAL
52
n
52
VAL
52
A
ILE
53
n
53
ILE
53
A
PHE
54
n
54
PHE
54
A
LEU
55
n
55
LEU
55
A
GLU
56
n
56
GLU
56
A
VAL
57
n
57
VAL
57
A
ASP
58
n
58
ASP
58
A
VAL
59
n
59
VAL
59
A
ASP
60
n
60
ASP
60
A
ASP
61
n
61
ASP
61
A
ALA
62
n
62
ALA
62
A
GLN
63
n
63
GLN
63
A
ASP
64
n
64
ASP
64
A
VAL
65
n
65
VAL
65
A
ALA
66
n
66
ALA
66
A
SER
67
n
67
SER
67
A
GLU
68
n
68
GLU
68
A
ALA
69
n
69
ALA
69
A
GLU
70
n
70
GLU
70
A
VAL
71
n
71
VAL
71
A
LYS
72
n
72
LYS
72
A
ALA
73
n
73
ALA
73
A
THR
74
n
74
THR
74
A
PRO
75
n
75
PRO
75
A
THR
76
n
76
THR
76
A
PHE
77
n
77
PHE
77
A
GLN
78
n
78
GLN
78
A
PHE
79
n
79
PHE
79
A
PHE
80
n
80
PHE
80
A
LYS
81
n
81
LYS
81
A
LYS
82
n
82
LYS
82
A
GLY
83
n
83
GLY
83
A
GLN
84
n
84
GLN
84
A
LYS
85
n
85
LYS
85
A
VAL
86
n
86
VAL
86
A
GLY
87
n
87
GLY
87
A
GLU
88
n
88
GLU
88
A
PHE
89
n
89
PHE
89
A
SER
90
n
90
SER
90
A
GLY
91
n
91
GLY
91
A
ALA
92
n
92
ALA
92
A
ASN
93
n
93
ASN
93
A
LYS
94
n
94
LYS
94
A
GLU
95
n
95
GLU
95
A
LYS
96
n
96
LYS
96
A
LEU
97
n
97
LEU
97
A
GLU
98
n
98
GLU
98
A
ALA
99
n
99
ALA
99
A
THR
100
n
100
THR
100
A
ILE
101
n
101
ILE
101
A
ASN
102
n
102
ASN
102
A
GLU
103
n
103
GLU
103
A
LEU
104
n
104
LEU
104
A
VAL
105
n
105
VAL
105
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
3
A
N
LYS
3
A
O
PHE
54
A
O
PHE
54
A
N
LEU
55
A
N
LEU
55
A
O
VAL
24
A
O
VAL
24
A
N
PHE
27
A
N
PHE
27
A
O
THR
76
A
O
THR
76
A
O
LYS
81
A
O
LYS
81
A
N
GLN
84
A
N
GLN
84
1
A
A
H
H2
VAL
HOH
52
207
1.27
1
A
A
HD21
H
ASN
LYS
93
96
1.29
2
A
A
H
H2
VAL
HOH
52
207
1.33
3
A
A
H
H1
VAL
HOH
52
207
1.28
5
A
A
H
H2
VAL
HOH
52
207
1.26
6
A
A
H
H1
VAL
HOH
52
207
1.28
6
A
A
H
H2
ASP
HOH
58
202
1.34
7
A
A
H
H2
VAL
HOH
52
207
1.27
8
A
A
H
H1
VAL
HOH
52
207
1.28
9
A
A
HD21
H
ASN
LYS
93
96
1.27
9
A
A
H
H2
VAL
HOH
52
207
1.28
11
A
A
H
H2
VAL
HOH
52
207
1.26
12
A
A
H
H2
VAL
HOH
52
207
1.28
13
A
A
H
H2
VAL
HOH
52
207
1.26
14
A
A
H
H2
VAL
HOH
52
207
1.27
15
A
A
H
H1
VAL
HOH
52
207
1.28
16
A
A
H
H2
VAL
HOH
52
207
1.27
17
A
A
H
H2
VAL
HOH
52
207
1.26
18
A
A
H
H2
VAL
HOH
52
207
1.28
19
A
A
H
H2
VAL
HOH
52
207
1.27
20
A
A
H
H1
VAL
HOH
52
207
1.30
21
A
A
H
H1
VAL
HOH
52
207
1.28
22
A
A
H
H2
VAL
HOH
52
207
1.28
22
A
A
HD21
H
ASN
LYS
93
96
1.28
23
A
A
H
H2
VAL
HOH
52
207
1.28
24
A
A
H
H1
VAL
HOH
52
207
1.30
25
A
A
H
H2
VAL
HOH
52
207
1.26
26
A
A
H
H2
VAL
HOH
52
207
1.28
27
A
A
H
H2
VAL
HOH
52
207
1.34
28
A
A
H
H2
VAL
HOH
52
207
1.27
29
A
A
H
H2
VAL
HOH
52
207
1.27
30
A
A
H
H2
VAL
HOH
52
207
1.27
32
A
A
H
H1
VAL
HOH
52
207
1.28
33
A
A
H
H1
VAL
HOH
52
207
1.28
34
A
A
H
H2
VAL
HOH
52
207
1.27
35
A
A
H
H2
VAL
HOH
52
207
1.26
36
A
A
H
H1
VAL
HOH
52
207
1.28
37
A
A
H
H1
VAL
HOH
52
207
1.27
38
A
A
H
H2
VAL
HOH
52
207
1.27
39
A
A
H
H2
VAL
HOH
52
207
1.29
40
A
A
H
H2
VAL
HOH
52
207
1.28
1
A
PHE
41
-115.02
-70.63
1
A
VAL
59
-63.32
6.81
1
A
ALA
62
-104.47
53.37
1
A
LYS
82
52.63
9.12
1
A
ASN
93
-103.22
73.37
2
A
PHE
41
-115.35
-70.59
2
A
ASN
51
-98.93
31.09
2
A
VAL
59
-63.53
6.24
2
A
ALA
62
-104.44
53.31
3
A
ASN
51
-99.42
30.31
3
A
VAL
59
-62.44
4.98
3
A
ALA
62
-105.02
54.39
3
A
LYS
82
51.60
11.75
4
A
PHE
41
-115.17
-70.04
4
A
ASN
51
-98.35
32.08
4
A
VAL
59
-63.35
7.71
4
A
ALA
62
-103.53
54.40
4
A
LYS
82
52.23
13.16
5
A
PHE
41
-115.39
-71.16
5
A
VAL
59
-63.01
6.87
5
A
ALA
62
-101.79
50.45
5
A
LYS
82
52.10
11.82
5
A
GLU
88
-172.06
147.20
5
A
ASN
93
-104.38
79.37
6
A
PRO
40
-69.24
5.09
6
A
LEU
45
-59.92
-9.96
6
A
ASN
51
-99.73
33.18
6
A
VAL
59
-63.48
8.58
6
A
ALA
62
-102.87
52.30
6
A
ALA
73
-151.79
85.94
6
A
LYS
82
52.66
9.16
6
A
ASN
93
-104.14
79.16
7
A
PHE
41
-116.29
-71.49
7
A
HIS
43
-65.94
0.05
7
A
ASN
51
-98.96
32.67
7
A
VAL
59
-63.43
7.02
7
A
ALA
62
-104.17
52.21
7
A
LYS
82
52.38
9.46
8
A
VAL
59
-63.44
6.51
8
A
ALA
62
-102.32
52.91
8
A
LYS
82
52.51
9.74
9
A
PHE
41
-115.23
-72.39
9
A
ASN
51
-99.33
31.02
9
A
VAL
59
-64.05
8.26
9
A
ALA
62
-104.95
53.53
9
A
LYS
82
52.29
9.40
9
A
GLU
88
-171.15
144.75
9
A
ASN
93
-105.92
79.87
10
A
PHE
41
-115.67
-70.26
10
A
VAL
59
-63.42
6.78
10
A
ALA
62
-103.27
50.88
10
A
GLU
70
39.21
46.68
10
A
ALA
73
-151.50
85.66
10
A
LYS
82
53.85
7.65
10
A
GLU
88
-171.66
144.99
11
A
PHE
41
-115.57
-70.45
11
A
LEU
45
-59.98
-8.76
11
A
ASN
51
-98.94
32.38
11
A
VAL
59
-63.53
7.88
11
A
ALA
62
-103.58
53.45
11
A
LYS
82
54.21
5.53
11
A
ASN
93
-104.79
79.92
12
A
PRO
40
-69.73
2.56
12
A
PHE
41
-115.63
-71.67
12
A
ASN
51
-99.23
32.16
12
A
VAL
59
-63.59
4.58
12
A
ALA
62
-103.11
48.48
12
A
LYS
82
51.94
10.08
12
A
GLU
88
-172.08
146.41
13
A
PRO
40
-69.95
5.66
13
A
PHE
41
-115.68
-70.17
13
A
VAL
59
-63.18
5.57
13
A
ALA
62
-102.81
51.46
13
A
LYS
82
51.85
12.79
13
A
GLU
88
-171.32
148.91
13
A
ASN
93
-105.27
78.34
14
A
ASN
51
-99.23
33.25
14
A
VAL
59
-63.45
6.82
14
A
ALA
62
-103.44
57.80
14
A
LYS
82
52.33
8.46
14
A
GLU
88
-171.92
146.46
14
A
ALA
92
-80.04
49.16
14
A
ASN
93
-104.72
78.08
15
A
PHE
41
-115.73
-70.53
15
A
VAL
59
-63.50
5.95
15
A
ALA
62
-103.57
49.41
15
A
LYS
82
52.10
13.38
15
A
GLU
88
-171.99
147.91
15
A
ASN
93
-104.62
79.72
16
A
PRO
40
-69.84
5.69
16
A
VAL
59
-63.85
7.48
16
A
ALA
62
-103.11
50.05
16
A
LYS
82
52.58
9.25
16
A
ASN
93
-103.99
78.65
17
A
VAL
59
-62.78
4.35
17
A
ALA
62
-103.90
48.12
17
A
LYS
82
51.77
14.72
18
A
PHE
41
-115.41
-70.65
18
A
ASN
51
-99.32
32.30
18
A
VAL
59
-63.24
6.14
18
A
ALA
62
-103.41
50.95
18
A
LYS
82
52.41
10.45
18
A
GLU
88
-172.10
146.72
19
A
ASN
51
-99.20
31.34
19
A
VAL
59
-62.92
6.61
19
A
ALA
62
-105.02
54.44
19
A
LYS
82
52.19
12.76
20
A
PHE
41
-116.28
-70.78
20
A
HIS
43
-65.60
0.06
20
A
VAL
59
-63.18
5.67
20
A
ALA
62
-102.99
47.92
20
A
LYS
82
52.53
10.16
21
A
PHE
41
-115.29
-71.53
21
A
VAL
59
-63.88
7.78
21
A
ALA
62
-103.50
51.68
21
A
LYS
82
52.28
12.39
22
A
PHE
41
-115.48
-70.56
22
A
ASN
51
-99.81
31.87
22
A
VAL
59
-63.79
7.78
22
A
ALA
62
-104.10
54.07
22
A
LYS
82
52.42
13.42
23
A
CYS
32
-46.61
166.97
23
A
PHE
41
-114.99
-70.51
23
A
ASN
51
-99.49
33.11
23
A
VAL
59
-66.49
24.49
23
A
ALA
62
-101.69
57.30
23
A
ALA
73
-151.52
89.83
23
A
LYS
82
52.29
9.99
23
A
GLU
88
-171.54
148.80
24
A
PHE
41
-115.62
-72.43
24
A
ASN
51
-99.64
33.88
24
A
VAL
59
-63.81
7.41
24
A
ALA
62
-104.05
52.37
24
A
LYS
82
51.61
11.14
25
A
PHE
41
-116.10
-70.63
25
A
VAL
59
-63.69
7.17
25
A
ALA
62
-103.49
53.07
25
A
LYS
82
52.30
11.05
25
A
ALA
92
-80.89
46.59
25
A
ASN
93
-102.93
73.66
26
A
PHE
41
-115.33
-72.59
26
A
ASN
51
-99.29
32.77
26
A
VAL
59
-63.30
6.07
26
A
ALA
62
-103.16
50.40
26
A
ALA
73
-152.17
89.14
26
A
LYS
82
51.77
9.94
26
A
GLU
98
-66.46
-70.24
27
A
PHE
41
-115.39
-70.30
27
A
ASN
51
-98.37
31.31
27
A
VAL
59
-63.18
6.21
27
A
ALA
62
-101.86
49.16
27
A
ALA
73
-152.16
89.44
27
A
LYS
82
52.40
9.80
27
A
GLU
88
-172.66
146.37
28
A
ASN
51
-99.18
32.11
28
A
VAL
59
-62.95
4.95
28
A
ALA
62
-103.91
51.43
28
A
LYS
82
52.45
9.60
28
A
ASN
93
-104.63
74.31
29
A
PHE
41
-115.39
-70.09
29
A
LEU
45
-59.94
-7.89
29
A
VAL
59
-62.95
5.23
29
A
ALA
62
-103.33
53.36
29
A
LYS
82
51.71
14.53
30
A
VAL
59
-63.54
6.34
30
A
ALA
62
-102.53
50.68
30
A
ALA
73
-151.95
88.38
30
A
LYS
82
52.13
13.48
30
A
ASN
93
-103.59
79.19
31
A
HIS
43
-65.62
0.47
31
A
ASN
51
-98.67
30.58
31
A
VAL
59
-63.74
8.41
31
A
ALA
62
-104.00
52.64
31
A
LYS
82
51.79
10.30
31
A
GLU
88
-172.11
148.15
32
A
PHE
41
-115.46
-70.27
32
A
ASN
51
-99.66
31.14
32
A
VAL
59
-63.23
5.94
32
A
ALA
62
-104.21
51.03
32
A
LYS
82
51.62
10.98
32
A
ALA
92
-79.75
49.88
32
A
ASN
93
-104.15
75.14
33
A
ILE
38
-95.34
30.59
33
A
PHE
41
-116.35
-71.08
33
A
HIS
43
-65.35
0.23
33
A
VAL
59
-63.31
7.08
33
A
ALA
62
-103.91
52.25
33
A
LYS
82
52.50
13.62
33
A
GLU
88
-171.67
147.07
33
A
ASN
93
-104.36
74.89
34
A
ASN
51
-99.19
32.06
34
A
VAL
59
-63.35
6.35
34
A
ALA
62
-103.97
54.45
34
A
LYS
82
52.09
9.40
34
A
GLU
88
-172.05
149.62
34
A
ALA
92
-79.91
48.22
34
A
ASN
93
-104.12
76.61
35
A
CYS
32
-49.45
166.29
35
A
PHE
41
-115.73
-70.41
35
A
VAL
59
-62.83
4.93
35
A
ALA
62
-101.57
53.83
35
A
LYS
82
52.02
10.71
36
A
PRO
40
-66.82
2.47
36
A
ASN
51
-99.83
31.70
36
A
VAL
59
-62.68
5.87
36
A
ALA
62
-103.72
56.52
36
A
LYS
82
51.62
12.81
36
A
ASN
93
-104.46
78.72
37
A
PHE
41
-115.28
-70.52
37
A
VAL
59
-62.71
6.35
37
A
ALA
62
-102.83
54.27
37
A
LYS
82
52.28
16.54
37
A
ASN
93
-103.61
74.39
38
A
PHE
41
-115.22
-70.44
38
A
ASN
51
-99.43
30.34
38
A
VAL
59
-63.39
6.45
38
A
ALA
62
-102.92
51.94
38
A
LYS
82
53.47
19.31
38
A
GLU
88
-171.50
148.62
39
A
PHE
41
-115.28
-70.13
39
A
ASN
51
-98.82
31.85
39
A
VAL
59
-62.89
5.41
39
A
ALA
62
-103.62
50.45
39
A
LYS
82
52.74
9.18
40
A
PRO
40
-69.90
6.51
40
A
ASN
51
-99.15
31.74
40
A
VAL
59
-62.95
6.00
40
A
ALA
62
-103.62
50.28
40
A
LYS
82
52.40
12.86
THE HIGH-RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURES OF THE OXIDIZED AND REDUCED STATES OF HUMAN THIOREDOXIN
1
Y
N
2
N
N
A
SER
7
A
SER
7
HELX_P
A
GLY
19
A
GLY
19
1
1
13
A
CYS
35
A
CYS
35
HELX_P
A
LYS
39
A
LYS
39
5
2
5
A
SER
44
A
SER
44
HELX_P
A
TYR
49
A
TYR
49
1
3
6
A
ALA
62
A
ALA
62
HELX_P
A
ALA
69
A
ALA
69
1
4
8
A
ASN
93
A
ASN
93
HELX_P
A
ASN
102
A
ASN
102
1
5
10
disulf
2.022
A
CYS
32
A
SG
CYS
32
1_555
A
CYS
35
A
SG
CYS
35
1_555
ELECTRON TRANSPORT
ELECTRON TRANSPORT
A
THR
74
A
THR
74
1
A
PRO
75
A
PRO
75
-1.03
A
THR
74
A
THR
74
2
A
PRO
75
A
PRO
75
-1.07
A
THR
74
A
THR
74
3
A
PRO
75
A
PRO
75
-1.06
A
THR
74
A
THR
74
4
A
PRO
75
A
PRO
75
-1.27
A
THR
74
A
THR
74
5
A
PRO
75
A
PRO
75
-1.16
A
THR
74
A
THR
74
6
A
PRO
75
A
PRO
75
-1.20
A
THR
74
A
THR
74
7
A
PRO
75
A
PRO
75
-1.11
A
THR
74
A
THR
74
8
A
PRO
75
A
PRO
75
-1.02
A
THR
74
A
THR
74
9
A
PRO
75
A
PRO
75
-1.18
A
THR
74
A
THR
74
10
A
PRO
75
A
PRO
75
-1.08
A
THR
74
A
THR
74
11
A
PRO
75
A
PRO
75
-1.09
A
THR
74
A
THR
74
12
A
PRO
75
A
PRO
75
-1.07
A
THR
74
A
THR
74
13
A
PRO
75
A
PRO
75
-1.07
A
THR
74
A
THR
74
14
A
PRO
75
A
PRO
75
-1.08
A
THR
74
A
THR
74
15
A
PRO
75
A
PRO
75
-1.05
A
THR
74
A
THR
74
16
A
PRO
75
A
PRO
75
-1.01
A
THR
74
A
THR
74
17
A
PRO
75
A
PRO
75
-1.11
A
THR
74
A
THR
74
18
A
PRO
75
A
PRO
75
-1.11
A
THR
74
A
THR
74
19
A
PRO
75
A
PRO
75
-0.98
A
THR
74
A
THR
74
20
A
PRO
75
A
PRO
75
-1.02
A
THR
74
A
THR
74
21
A
PRO
75
A
PRO
75
-1.14
A
THR
74
A
THR
74
22
A
PRO
75
A
PRO
75
-1.03
A
THR
74
A
THR
74
23
A
PRO
75
A
PRO
75
-1.12
A
THR
74
A
THR
74
24
A
PRO
75
A
PRO
75
-1.11
A
THR
74
A
THR
74
25
A
PRO
75
A
PRO
75
-1.06
A
THR
74
A
THR
74
26
A
PRO
75
A
PRO
75
-1.06
A
THR
74
A
THR
74
27
A
PRO
75
A
PRO
75
-1.05
A
THR
74
A
THR
74
28
A
PRO
75
A
PRO
75
-1.10
A
THR
74
A
THR
74
29
A
PRO
75
A
PRO
75
-1.12
A
THR
74
A
THR
74
30
A
PRO
75
A
PRO
75
-1.03
A
THR
74
A
THR
74
31
A
PRO
75
A
PRO
75
-1.10
A
THR
74
A
THR
74
32
A
PRO
75
A
PRO
75
-1.08
A
THR
74
A
THR
74
33
A
PRO
75
A
PRO
75
-0.91
A
THR
74
A
THR
74
34
A
PRO
75
A
PRO
75
-0.97
A
THR
74
A
THR
74
35
A
PRO
75
A
PRO
75
-1.17
A
THR
74
A
THR
74
36
A
PRO
75
A
PRO
75
-1.07
A
THR
74
A
THR
74
37
A
PRO
75
A
PRO
75
-1.09
A
THR
74
A
THR
74
38
A
PRO
75
A
PRO
75
-0.99
A
THR
74
A
THR
74
39
A
PRO
75
A
PRO
75
-1.17
A
THR
74
A
THR
74
40
A
PRO
75
A
PRO
75
-1.16
THIO_HUMAN
UNP
1
1
P10599
VKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFK
KGQKVGEFSGANKEKLEATINELV
1
104
1TRU
2
105
P10599
A
1
2
105
1
CYS
conflict
ALA
62
1TRU
A
P10599
UNP
61
62
1
CYS
conflict
ALA
69
1TRU
A
P10599
UNP
68
69
1
CYS
conflict
ALA
73
1TRU
A
P10599
UNP
72
73
1
MET
conflict
THR
74
1TRU
A
P10599
UNP
73
74
5
parallel
parallel
anti-parallel
anti-parallel
A
VAL
2
A
VAL
2
A
ILE
5
A
ILE
5
A
ILE
53
A
ILE
53
A
ASP
58
A
ASP
58
A
VAL
23
A
VAL
23
A
SER
28
A
SER
28
A
THR
76
A
THR
76
A
LYS
81
A
LYS
81
A
GLN
84
A
GLN
84
A
SER
90
A
SER
90
1
P 1